Magellan Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Magellan Health generated cash of $450,761,000, which is more than the previous year. Cash used in financing activities reached the amount of $13,137,000 last year. Net change in cash is therefore $1,028,698,000.
Cash Flow
| 2011 | 112.00M | 16.26M | -345.58M |
|---|---|---|---|
| 2012 | 181.29M | -110.56M | -1.12M |
| 2013 | 183.16M | -155.90M | -13.53M |
| 2014 | 211.04M | -255.12M | 96.20M |
| 2015 | 239.18M | -193.18M | -185.86M |
| 2016 | 66.69M | -244.33M | 233.11M |
| 2017 | 162.27M | -316.39M | 248.34M |
| 2018 | 164.84M | -128.43M | -162.83M |
| 2019 | 115.84M | -19.49M | -43.41M |
| 2020 | 450.76M | 678.93M | 13.13M |
MGLN Cash Flow Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 115.75M | 272.30M | 398.73M | 304.50M | 249.02M | 255.30M | 203.18M | 189.46M | 119.86M | 337.17M |
Operating activities | ||||||||||
Net income | 382.33M | 55.90M | 24.18M | 110.20M | 77.87M | 31.41M | 79.40M | 125.26M | 151.02M | 129.62M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 118.74M | 131.50M | 132.66M | 115.70M | 106.04M | 102.84M | 91.07M | 71.99M | 60.48M | 58.62M |
Stock-based compensation expense | 25.45M | 25.50M | 29.47M | 39.11M | 37.42M | 50.38M | 40.58M | 21.25M | 17.78M | 17.41M |
| Deferred income tax benefit | 25.45M | 25.50M | 29.47M | 39.11M | 37.42M | 50.38M | 40.58M | 21.25M | 17.78M | 17.41M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 17.07M | -133.99M | -99.29M | -40.91M | -134.08M | -52.39M | -74.60M | -40.80M | -16.41M | -15.60M |
Inventories | 1.62M | -4.14M | 127K | 17.60M | -8.24M | -11.37M | 10.23M | -3.88M | -6.16M | -11.65M |
Accounts payable | 225.05M | 56.84M | 9.13M | -84.44M | 52.47M | -36.04M | 5.88M | 3.59M | -8.32M | 0 |
Cash generated by operating activities | 450.76M | 115.84M | 164.84M | 162.27M | 66.69M | 239.18M | 211.04M | 183.16M | 181.29M | 112.00M |
Investing activities | ||||||||||
Purchases Of Investments | -804.15M | -514.32M | -557.23M | -449.87M | -478.47M | -470.09M | -340.96M | -323.25M | -321.54M | -259.55M |
Investments In Property Plant And Equipment | -75.48M | -60.40M | -68.27M | -57.23M | -60.88M | -71.58M | -62.33M | -64.54M | 0 | 0 |
Acquisitions Net | 913.22M | -727K | -958K | -232.40M | -199.23M | -55.81M | -128.27M | -107.54M | -1.22M | -376K |
Cash generated by investing activities | 678.93M | -19.49M | -128.43M | -316.39M | -244.33M | -193.18M | -255.12M | -155.90M | -110.56M | 16.26M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -4.12M | -62.64M | -21.76M | -106.80M | -206.04M | -197.53M | -60.67M | -21.86M | -407.64M |
Repayments of term debt | -131.66M | 0 | -122.23M | 0 | -20.89M | 0 | -8.04M | -3.00M | 0 | -559K |
Cash used in financing activities | 13.13M | -43.41M | -162.83M | 248.34M | 233.11M | -185.86M | 96.20M | -13.53M | -1.12M | -345.58M |
Net Change In Cash | 1.02B | 52.94M | -126.42M | 94.22M | 55.47M | -139.87M | 52.11M | 13.72M | 69.60M | -217.31M |
Cash at end of period | 1.14B | 325.24M | 272.30M | 398.73M | 304.50M | 115.43M | 255.30M | 203.18M | 189.46M | 119.86M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |